NCT04926285 2026-03-16
VEN-OM
University of Illinois at Chicago
Phase 1 Completed
Clinical Trials
3 trialsNCT01844869 2015-01-30
An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1 Completed
NCT00675350 2014-05-12
Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1 Completed